Acorai
                                                                                                                                    
                                                                                                Sweden
                                                 -                                                 Helsingborg
                                                                                            
                                                                                    - 22/01/2024
 - Unknown
 - Undisclosed Amount
 
Acorai is developing a device for heart failure management through non-invasive intracardiac pressure monitoring (ICPM), to help reduce hospitalizations and readmissions. Our product, The Acorai Heart Monitor, can monitor intracardiac pressures non-invasively through a machine learning analysis of pressure dynamics in acoustics, vibratory and waveform data. Our technology show compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement and a fast track to commercialization.
- Industry Medical Equipment Manufacturing
 - Website https://acorai.com/
 - LinkedIn https://www.linkedin.com/company/acorai/about/
 
Related People
Filip PetersFounder
                                                    
                                                                                                                Sweden -
                                                         ND
                                                    
                                                Acorai's vision is to prevent heart failure hospitalizations by transforming the treatment and management of the disease through novel sensor solutions and applied machine learning. Interested in learning more? Get in touch!
                                Vesence |  $9,000,000  | (Oct 30, 2025)
                            
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                            
                                Reflectiz |  $22,000,000  | (Oct 30, 2025)
                            
                                    
                                    
                                    
                                    
                                    
                                            
                                                
                                                    
                                                
                                                    
                                                
                                                
                                                
                                                
                                                
                                                
                                                    
                                                
                                                
                                                                        
                                Mem0 |  $24,000,000  | (Oct 30, 2025)
                                                                        
                                Valthos |  $30,000,000  | (Oct 30, 2025)
                                                                        
                                Mondra |  $13,206,500  | (Oct 30, 2025)
                                                                        
                                hoop.dev |  Undisclosed Amount  | (Oct 30, 2025)
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                FrontlineIQ |  $3,300,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                VentureMed Inc. |  $28,000,000  | (Oct 30, 2025)
                                                                        
                                Recess |  $30,000,000  | (Oct 30, 2025)